| Stereochemistry | RACEMIC |
| Molecular Formula | C18H18N4O2 |
| Molecular Weight | 322.3611 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(CC1=CC=CC=C1)[N+]2=NOC([N-]C(=O)NC3=CC=CC=C3)=C2
InChI
InChIKey=OWFUPROYPKGHMH-UHFFFAOYSA-N
InChI=1S/C18H18N4O2/c1-14(12-15-8-4-2-5-9-15)22-13-17(24-21-22)20-18(23)19-16-10-6-3-7-11-16/h2-11,13-14H,12H2,1H3,(H-,19,20,21,23)
Mesocarb (sydnocarb or 3-(beta-phenylisopropyl)-N-phenylcarbamoylsydnonimine) is a psychomotor stimulant N-alkylated amphetamine derivative. Mesocarb is a selective inhibitor of dopamine uptake, it potently blocks dopamine transporter. It is very likely that mesocarb is being used by drug addicts. Mesocarb is included in the World Anti-Doping Agency’s list of substances and methods that are prohibited in sports. It is used in Russia for the treatment of a variety of neuropsychiatric comorbidities.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 8.3 nM [Ki] |
PubMed
Patents
Sample Use Guides
The drug is administered orally, before meals, 1-2 times a day in the first half of the day. Adults: initial dose of 0.005 g / day; if necessary - up to 0,015-0,05 g / day; maintenance dose - 0.005-0.01 g / day, the highest single dose - 0.075 g, daily - 0.15 g
Route of Administration:
Oral
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
